DK0968174T3 - Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok - Google Patents

Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok

Info

Publication number
DK0968174T3
DK0968174T3 DK98902173T DK98902173T DK0968174T3 DK 0968174 T3 DK0968174 T3 DK 0968174T3 DK 98902173 T DK98902173 T DK 98902173T DK 98902173 T DK98902173 T DK 98902173T DK 0968174 T3 DK0968174 T3 DK 0968174T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
aminotetralin
septic shock
Prior art date
Application number
DK98902173T
Other languages
Danish (da)
English (en)
Inventor
Gian Piero Moretti
Piero Foresta
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK0968174T3 publication Critical patent/DK0968174T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK98902173T 1997-02-03 1998-01-28 Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok DK0968174T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000050A IT1290910B1 (it) 1997-02-03 1997-02-03 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
PCT/IT1998/000011 WO1998033762A1 (en) 1997-02-03 1998-01-28 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock

Publications (1)

Publication Number Publication Date
DK0968174T3 true DK0968174T3 (da) 2003-05-12

Family

ID=11404706

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98902173T DK0968174T3 (da) 1997-02-03 1998-01-28 Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok

Country Status (11)

Country Link
US (1) US6225501B1 (de)
EP (1) EP0968174B1 (de)
JP (1) JP2001509802A (de)
AT (1) ATE231486T1 (de)
DE (1) DE69810906T2 (de)
DK (1) DK0968174T3 (de)
ES (1) ES2190581T3 (de)
HK (1) HK1025558A1 (de)
IT (1) IT1290910B1 (de)
PT (1) PT968174E (de)
WO (1) WO1998033762A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294931B1 (it) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
IT1317050B1 (it) * 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Tetraline 2,6,7-sostituite utili per la preparazione di un medicamentoad attivita' inibitrice della fosfodiesterasi iv.
CN103360360A (zh) * 2012-04-10 2013-10-23 肖竹平 一种基于二氢杨梅素制备(+)-没食子儿茶素的方法
CN112153968A (zh) 2017-10-05 2020-12-29 生物基因公司 制备α-羧酰胺吡咯烷衍生物的工艺
EA202192764A1 (ru) * 2019-04-10 2022-03-10 Байоджен Инк. Способы получения производных альфа-карбоксамид пирролидина
CN115724758A (zh) * 2021-08-24 2023-03-03 杭州中美华东制药有限公司 喜树碱衍生物中间体及其合成方法和利用中间体合成喜树碱衍生物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
IT1278045B1 (it) * 1995-03-09 1997-11-17 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Also Published As

Publication number Publication date
JP2001509802A (ja) 2001-07-24
WO1998033762A1 (en) 1998-08-06
EP0968174A1 (de) 2000-01-05
IT1290910B1 (it) 1998-12-14
US6225501B1 (en) 2001-05-01
ES2190581T3 (es) 2003-08-01
HK1025558A1 (en) 2000-11-17
DE69810906D1 (de) 2003-02-27
ITRM970050A1 (it) 1998-08-03
EP0968174B1 (de) 2003-01-22
DE69810906T2 (de) 2003-11-13
ATE231486T1 (de) 2003-02-15
PT968174E (pt) 2003-06-30

Similar Documents

Publication Publication Date Title
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
BR9206070A (pt) Processo para tratar vidro de fluoroaluminossilicato, vidro de fluoroaluminossilicato tratado e alcoxissilanos poliméricos etilenicamente insaturados.
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
DK0858330T3 (da) Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom
DE60010456D1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
EP0908186A3 (de) Verfahren zur Schmerzbehandlung
ZA200108684B (en) Method of enhancing biological effectiveness of plant treatment compositions.
ITTO930547A0 (it) Procedimento e macchina per sterilizzare o disinfettare i rifiuti.
BR9204924A (pt) Associacao agroquimica,composicao agroquimica e processo de tratamento de plantas
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
DK0968174T3 (da) Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
DE69721756D1 (de) Paroxetine zur behandlung von depression
MX9800589A (es) Tratamiento de desorden de la falta de atencion/hiperactividad.
ATE204705T1 (de) Pflaster zur behandlung von pflanzen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DK0888330T3 (da) Fremgangsmåder til behandling eller forebyggelse af interstitiel cystitis
FI950278A (fi) Menetelmä jätteiden käsittelemiseksi, jätteidenkäsittelyjärjestelmä ja jätesäiliö
ATE323493T1 (de) Gesteuerte freisetzung von antidepressiva
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
MX9601031A (es) Composicion farmaceutica para el tratamiento y prevencion del cancer de prostata.
AP9801416A0 (en) Method Of treating a plant disease.
MY129918A (en) Method for treating hypertension.